September 22, 2015 at 10:00 AM
Johnson & Johnson And The Big Lies Of Big Pharma
The drug industry, and “sales over science.” Muckracker journalist Steven Brill goes after Johnson & Johnson and more. He’s with us.
A collection of children-specific promotional materials for Johnson & Johnson’s anti-psychotic Risperdal drug. (Courtesy Huffington Post)
Drug companies are in the news for gigantic price increases on their drugs lately. Mind-blowing increases that can look completely arbitrary. But that’s not the only big story on the pharmaceutical industry. Muckraking journalist Steven Brill is going after the iconic brand Johnson & Johnson for its handling of a drug that made it billions but was not a win for a bunch of patients. The company is paying billions in fines and settlements, but making more. Billions more. Brill is with us. This hour On Point, the latest on the huge drug prices hikes, and Steven Brill on the charge of “sales over science” at Johnson & Johnson.